HIV Diagnosis Market - Global Industry Analysis, Size, Share, Trends, Analysis, Growth, and Forecast 2017 - 2025
Global HIV Diagnosis Market: Snapshot
Human immunodeficiency virus (HIV) is the virus responsible for incidence of the disease acquired immunodeficiency syndrome (AIDS) which is caused by the constant decline in T-helper cells in the body. HIV has been a key contributor to global burden of diseases, particularly considering its role in disability-adjusted life year (DALY). The virus can considerably weaken the immune system by attacking different cells, notably CD4+ T cells, macrophages, and dendritic cells. Among the two key subtypes, HIV-1 is more virulent. The HIV diagnostic testing since its inception has transformed the management of AIDS in patient populations and the reduction of HIV cases globally. The laboratory diagnosis of the infections has made some bold strides since it started in 1980s.
Presently, enzyme immunoassays have emerged as the most popular assay to test the presence of HIV by detecting antibody just two weeks after an individual has been infected. In addition to this, several other assays have emerged such as polymerase chain reaction [PCR] and Western blot. Apart from the appropriate choice of assays, the accurate laboratory diagnosis depends on several other factors. The use of modern testing algorithms, adherence to good laboratory quality control practices, and easy to be performed by clinic staff are some of the key aspects for reliable and helpful HIV testing. Moreover, the results must be clinically relevant. In this regard, rapid diagnostic tests (RDTs) in in-vitro format and point-of-care settings have emerged as a compelling proposition. The format is easy to perform by healthcare professionals and does not require any elaborate preparation, including any additional equipment. Thus these tests for HIV diagnosis find widespread usage in community- and facility-based settings in regions that lack adequate healthcare infrastructure. Advances in antiretroviral therapy and vaccines have emerged as the highly promising for expanding the therapeutic and preventive options for the diagnosis of the virus.
Global HIV Diagnosis Market: Overview
HIV stands for human immunodeficiency virus, which when left unattended causes AIDS (acquires immunodeficiency syndrome). This virus attacks cells of the immune system of human body and unlike other viruses, the body can’t get rid of it completely. The growing prevalence of HIV/AIDS is by far the leading factor augmenting the global HIV diagnosis market. According to the Joint United Nations Programme on HIV and AIDS (UNAIDS), approximately 36.7 people around the world were suffering from HIV/AIDS at the end of 2015.
Global HIV Diagnosis Market: Key Trends
The soaring need for accurate and cost-effective diagnostic tests is leading to the increasing reliance on point-of-care instruments and kits. Benefits of these kits, including quick diagnosis, cost-effectiveness, robustness, and minimal equipment requirement, are driving their uptake, which in turn is escalating the growth of the global HIV diagnosis market. The growing number of blood transfusions and blood donations increases the chances of HIV infection, thus, promoting the people around the world to take diagnostic tests. Moreover, the increasing initiatives by governments worldwide are working in favor of the market. On the other hand, the high cost of the nucleic acid test (NAT) along with the lack of proper regulatory structure for NAT in developing countries is hampering the growth of the market.
Global HIV Diagnosis Market: Market Potential
The rising preference of home access kits and instruments along with the increasing research and development activities in the field is leading to the introduction of novel homecare technologies for diagnosis of HIV infection. Advanced technologies allow simultaneous detection and quantification of multiple targets in an accurate and cost-effective manner. For instance, in November 2016, a team of researchers from the Imperial College of London and DNA Electronics coined a discreet USB stick that uses a drop of blood to diagnose HIV in patients. This home HIV testing kit is capable of providing results in 30 minutes in comparison with conventional tests that take up to two weeks to process. The introduction of such technologies for homecare setup is, therefore, unfolding immense growth opportunities for the market.
Global HIV Diagnosis Market: Geographical Segmentation
Geographically, North America will represent a major share in the market throughout the review period. The high prevalence of HIV and increasing blood transfusions are the primary factors behind the development of the HIV diagnosis market in the region. Rising uptake of the technologically advanced diagnostic solutions, improving consumer spending power on healthcare, and growing inclination towards portable and point of care tests are also supplementing the growth of the region. In North America, the U.S. is at the forefront of growth owing to the significant budget allocated by the government for research and development in the field of HIV/AIDS testing. Moreover, favorable reimbursement policies in the U.S. are encouraging patients to uptake HIV diagnosis tests.
Asia Pacific will be an emerging market for HIV diagnosis. The presence of a large pool of patients suffering from HIV/AIDS along with the rising awareness regarding the populace is fuelling the growth of the region. The improving healthcare infrastructure in emerging economies will play a vital role in providing momentum to the market in APAC.
Global HIV Diagnosis Market: Competitive Landscape
The majority of players in the global HIV diagnosis market are pouring funds into research and development activities to stay ahead. The market is characterized by high competitive rivalry, which is likely to intensify in the near future as more players decide to go the mergers and acquisitions way to consolidate their presence. Large players are focusing towards collaborations and agreements with smaller market entities to capitalize untapped markets. Some of the prominent companies operating in the market are Siemens Healthcare, Alere Inc., Roche Diagnostics, Danaher Corporation, Becton, Dickson and Company, Merck KgaA, and Abbott Healthcare.
The study presents a granular assessment and quantitative evaluation of:
The region-wise assessment includes market dynamics in:
The study is prepared with the help of an extensive primary and secondary research. Primary research includes but not limited to interactions, interviews, surveys, and events. Opinions of policy makers and industry experts are carefully integrated into the insights to complement primary research. Volumes of secondary data gleaned through renowned paid sources, annual statements, reputed journals, and government documents offer insights into current dynamics and key evolution trajectories the market is likely to assume. The research employs various industry-wide analytics methods and well-established methodologies to ascertain the attractiveness of key segments. Further, it evaluates the lucrativeness of key regions and factors underlying their maturity. The insights notably include a detailed analysis of forces behind vendor differentiation and offers insight into investment-decision making by prominent players.
The report strives to enlighten businesses and industry stakeholders on multiple facets of the growth dynamic of the market, the key of which include answers to:
Note: Utmost care has invariably been taken to present data and arrive at statistics at all the TMR Research reports. Meanwhile, some recent developments and new industry trends may take time to be included in the reports.
Flat 10% discount on Single User License if you prebook this report
Flat 10% discount on Multiple User License if you prebook this report
Flat 10% discount on Corporate License if you prebook this report